All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-CD44 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-1086-YY | 5C10 | Mouse | IgG2b, κ | |||
DMAb-1076-YY | 3H1355 | Mouse | IgG2b | Recognizes an epitope encoded by exons v7-v8 on the variant portion of human CD44 | ||
DMAb-0247-CN | CVS18 | Mouse | IgG1 | |||
DMAb-0228-CQ | 156-3C11 | Mouse | IgG2a, κ | Stimulated human leukocytes | ||
DMAb-0230-CQ | CD44v4/1219 | Mouse | Human | IgG2a, κ | Recombinant fragment corresponding to the v4 domain of human CD44 | |
DMAb-0231-CQ | CD44v4/1700R | Rabbit | Human | IgG, κ | Recombinant fragment corresponding to the v4 domain of human CD44 | |
DMAb-0232-CQ | DF1485 | Mouse | IgG1, κ | Purified CD44 antigen (PGp-1) from lymphocyte membrane | ||
DMAb-0233-CQ | F10-44-2 | Mouse | Human | IgG2a | Purified human T cells | |
DMAb-0234-CQ | HCAM/1097 | Mouse | IgG1, κ | Recombinant human HCAM protein | ||
DMAb-0235-CQ | HCAM/918 | Mouse | IgG2a, κ | Recombinant human HCAM protein | ||
DMAb-0236-CQ | Hermes-1 | Rat | IgG2a | 80-95 kDa lymphocyte surface glycoprotein H-CAM (CD44) | ||
DMAb-0237-CQ | IM7 | Rat | IgG2b | Dexamethasone-induced cells of the SJL mouse spontaneous myeloid leukemia M1 | ||
DMAb-0238-CQ | MEM-263 | Mouse | IgG1 | COS-7 cells, African Green Monkey (NM_000610.3) | ||
DMAb-0239-CQ | MEM-85 | Mouse | Human | IgG2b | ||
DMAb-0240-CQ | P2A1 | Mouse | Human | IgG2a | Ocular melanoma cell line (V+B2) | |
DMAb-0241-CQ | SPM544 | Mouse | IgG2a, κ | Stimulated human leukocytes | ||
DMAb-0242-CQ | VFF-11 | Mouse | Human | IgG1 | Glutathione S Transferase (GST) fusion protein corresponding to the variable domains (v3 to v10) of human CD44 | |
DMAb-0243-CQ | VFF-17 | Mouse | Human | IgG2b | Made to Human CD44v7/8 | |
DMAb-0244-CQ | VFF-327 | Mouse | Human | IgG1 | Made to Human CD44v3 | |
DMAb-0245-CQ | VFF-8 | Mouse | Human | IgG1 | Made to Human CD44v5 | |
DMAb-0246-CQ | VFF-9 | Mouse | Human | IgG1 | Made to Human CD44v7 | |
DMAb-0249-CQ | DB105 | Mouse | IgG1 | |||
DMAb-0253-CQ | BU52 | Mouse | Human | IgG1 | ||
DMAb-0254-CQ | BU75 | Mouse | Human | IgG2a | ||
DMAb-0255-CQ | hCD44 | Mouse | Human | IgG1 | ||
DMAb-0256-CQ | Hermes-3 | Mouse | Human | IgG2a, κ | ||
DMAb-0257-CQ | HI44a | Mouse | Human | IgG1 | ||
DMAb-0258-CQ | SPM521 | Mouse | Human | IgG2a, κ | ||
DMAb-0260-CQ | KM201 | Rat | Mouse | IgG | ||
DMAb-0262-CQ | NKI-P2 | Mouse | Human | IgG1 | ||
DMAb-0264-CQ | BSB-12 | Mouse | Human | IgG2a | ||
DMAb-0267-CQ | HCM15-1 | Mouse | IgG1, κ | Purified human protein | ||
DMAb-0175-WJ | AV6 | Mouse | Chicken | IgG1 | ||
DMAb-0176-WJ | B-F24 | Mouse | Human | IgG1 | U937 cell line | |
DMAb-0253-CQ | BU52 | Mouse | Human | IgG1 | ||
DMAb-0254-CQ | BU75 | Mouse | Human | IgG2a | ||
DMAb-0230-CQ | CD44v4/1219 | Mouse | Human | IgG2a, κ | Recombinant fragment corresponding to the v4 domain of human CD44 (exact sequence is proprietary) | |
DMAb-0231-CQ | CD44v4/1700R | Rabbit | Human | IgG, κ | Recombinant fragment corresponding to the v4 domain of human CD44 (exact sequence is proprietary) | |
DMAb-0182-WJ | CD44v9/1459 | Mouse | Human | IgG1, κ | Recombinant fragment corresponding to the v9 domain of human CD44 (exact sequence is proprietary) | |
DMAb-0247-CN | CVS18 | Mouse | Equine | IgG1 | ||
DMAb-0233-CQ | F10-44-2 | Mouse | Human | IgG2a | CD44 antibody was raised in mouse using human CD44 as the immunogen | |
DMAb-0255-CQ | hCD44 | Mouse | Human | IgG1 | ||
DMAb-0236-CQ | Hermes-1 | Rat | IgG2a | 80 - 95 kDa lymphocyte surface glycoprotein H-CAM (CD44) | ||
DMAb-0257-CQ | HI44a | Mouse | Human | IgG2a | ||
DMAb-0237-CQ | IM7 | Rat | IgG2b, κ | |||
DMAb-0194-WJ | IM7.8.1 | Rat | Mouse | IgG2b | CD44 (Ly 24, Pgp-1) (Mouse CD44) | |
DMAb-0260-CQ | KM201 | Rat | Mouse | IgG1 | ||
DMAb-0198-WJ | KM81 | Rat | Mouse | IgG2a | ||
DMAb-0199-WJ | 9A4 | Rat | Mouse | IgG1 | ||
DMAb-0205-WJ | B-R8 | Mouse | Human | IgG1, κ | U266 cell line | |
DMAb-0232-CQ | DF1485 | Mouse | IgG1, κ | |||
DMAb-0234-CQ | HCAM/1097 | Mouse | Human | IgG1, κ | Recombinant human HCAM protein | |
DMAb-0235-CQ | HCAM/918 | Mouse | Human | IgG2a, κ | Recombinant human HCAM protein | |
DMAb-0256-CQ | Hermes-3 | Mouse | Human | IgG2a, κ | Recombinant protein corresponding to human CD44 (P16070) | |
DMAb-0227-WJ | J-173 | Mouse | Human | IgG1 | LAZ 221 ALL | |
DMAb-0174-YJ | 3H2606 | Mouse | Mouse | IgG1 | Spleen cells from B6PL-Ly-2a/Ly-3a B6-Ly-1a mice. |
There are currently no customer reviews or questions for Anti-CD44 DNA-encoded mAb (DMAb), pVAX1 (DMAb-1086-YY). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION